DDX16 Antibodies

Santa Cruz Biotechnology delivers a wide array of DDX16 monoclonal antibodies for research focused on understanding DDX16 protein functions. DDX16 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DDX16, also known as DEAD-box helicase 16, is involved in RNA metabolism and plays a critical role in the regulation of gene expression. DDX16 is essential for processes such as mRNA splicing, translation, and ribosome biogenesis, making it a key player in cellular function and development. Understanding DDX16 functions is vital for elucidating its implications in various diseases, including cancer and neurodegenerative disorders. Research has shown that DDX16 expression levels can vary significantly across different tissue types and developmental stages. DDX16 has emerged as a potential therapeutic target due to its role in RNA processing pathways. Ongoing studies continue to reveal new aspects of DDX16's biological significance in health and disease. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DDX16's role in cellular processes and disease mechanisms.